• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO. (SPARKS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Catalog Number 442963
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/06/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
Report 2 of 2.It was reported that while using bd max¿ enteric bacterial panel that there was 2 false positives.The following information was provided by the initial reporter: on the (b)(6) 2023, 2 samples of patients with acute gastroenteritis were measured positive on the bd max ct2207.Both samples had a good amplification and about 2000 rfus.The same samples were then tested on the (b)(6) and they were negative and there was no sign of amplification.
 
Event Description
Report 2 of 2.It was reported that while using bd max¿ enteric bacterial panel that there was 2 false positives.The following information was provided by the initial reporter: on the (b)(6) 2023, 2 samples of patients with acute gastroenteritis were measured positive on the bd max ct2207.Both samples had a good amplification and about 2000 rfus.The same samples were then tested on the 08th of september and they were negative and there was no sign of amplification.
 
Manufacturer Narrative
H3.Investigation summary: the complaint investigation for discrepant results when using the bd max¿ enteric bacterial panel assay (ref.442963) from lots 3081374 was performed by the review of the manufacturing records, review of customer¿s data and by the complaint¿s history review.Review of the manufacturing records of bd max¿ enteric bacterial panel assay indicated that lot 3081374 was manufactured according to specifications and met performance requirements.Customer complained about salmonella positive results on two patient samples which were later negative in culture and in the repeat test.Customer provided databases from instruments ct2207 and ct1211 for investigation.Additional information revealed that runs 519 and 524 from ct2207 and 2578 from ct1211 are the specific runs involved in the issue.Manual pcr curve adjudication of the salmonella positive samples (run 519, positions a2 and a3) revealed late and low, but true amplification, without anomaly indicative of true low positive results.After the initial run, new sample buffer tubes were prepared and tested in runs 524 and 2578 and gave salmonella negative results.Curves analysis of the repeat tests did not show any anomaly, suggesting true negative results.Low positive samples such as those obtained in the initial test can occur due to concentration in the specimen being at or near the limit of detection of the assay or through environmental or cross contamination introduced during the sample preparation at the customer¿s site.Moreover, limit of detection can vary between different assays.Nevertheless, manual curve adjudication has limitations; visual examination of pcr curves for low signal is a conservative assessment of the data.Bd was unable to identify the exact cause of the customer¿s discrepant results.Nonetheless, no reagents issue is suspected.The root cause was not identified.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on the bd max¿ enteric bacterial panel assay lot 3081374.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action (capa) since no new hazard was identified.Bd quality will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ ENTERIC BACTERIAL PANEL
Type of Device
GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17914008
MDR Text Key326265431
Report Number1119779-2023-01079
Device Sequence Number1
Product Code PCI
UDI-Device Identifier00382904429638
UDI-Public00382904429638
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K140111
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number442963
Device Lot Number3081374
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/22/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-